MCID: RMS001
MIFTS: 43

Rem Sleep Behavior Disorder

Categories: Mental diseases

Aliases & Classifications for Rem Sleep Behavior Disorder

MalaCards integrated aliases for Rem Sleep Behavior Disorder:

Name: Rem Sleep Behavior Disorder 12 55 44 15 73
Rapid Eye Movement Sleep Behavior Disorder 12

Classifications:



External Ids:

Disease Ontology 12 DOID:9091
ICD10 33 G47.52
ICD9CM 35 327.42
MeSH 44 D020187
UMLS 73 C0751772

Summaries for Rem Sleep Behavior Disorder

Disease Ontology : 12 A sleep disorder that involves abnormal behavior including the acting out of violent or dramatic dreams during the sleep phase with rapid eye movement.

MalaCards based summary : Rem Sleep Behavior Disorder, also known as rapid eye movement sleep behavior disorder, is related to machado-joseph disease and dementia, lewy body. An important gene associated with Rem Sleep Behavior Disorder is SNCA (Synuclein Alpha), and among its related pathways/superpathways are Neuroscience and Monoamine Transport. The drugs Suvorexant and Mianserin have been mentioned in the context of this disorder. Affiliated tissues include eye, brain and testes, and related phenotypes are behavior/neurological and homeostasis/metabolism

Wikipedia : 76 Rapid eye movement sleep behavior disorder (RBD) is a sleep disorder (more specifically a parasomnia) in... more...

Related Diseases for Rem Sleep Behavior Disorder

Diseases related to Rem Sleep Behavior Disorder via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 65)
# Related Disease Score Top Affiliating Genes
1 machado-joseph disease 32.5 RPS27A SLC6A3 SNCA
2 dementia, lewy body 32.1 ACHE LRRK2 RPS27A SLC6A3 SNCA
3 dementia 30.9 ACHE LRRK2 SLC6A3 SNCA
4 synucleinopathy 30.5 LRRK2 SLC6A3 SNCA
5 pure autonomic failure 30.4 ACHE SNCA
6 multiple system atrophy 1 30.3 LRRK2 RPS27A SLC6A3 SNCA
7 corticobasal degeneration 30.3 LRRK2 RPS27A
8 tremor 30.3 LRRK2 SNCA
9 parkinson disease, late-onset 30.2 ACHE HCRT LRRK2 RPS27A SLC6A3 SNCA
10 essential tremor 30.1 LRRK2 SLC6A3 SNCA
11 restless legs syndrome 30.0 HCRT SLC6A3 SNCA
12 supranuclear palsy, progressive, 1 29.9 ACHE LRRK2 RPS27A SLC6A3 SNCA
13 frontotemporal dementia 29.8 ACHE LRRK2 RPS27A SNCA
14 narcolepsy 10.6
15 sleep apnea 10.5
16 alzheimer disease 10.4
17 depression 10.3
18 multiple sclerosis 10.3
19 huntington disease 10.2
20 bruxism 10.2
21 limbic encephalitis 10.2
22 apnea, obstructive sleep 10.2
23 rheumatoid arthritis 10.2
24 arthritis 10.2
25 hereditary late-onset parkinson disease 10.2 LRRK2 SNCA
26 parkinson disease 10 10.2 LRRK2 SNCA
27 parkinson disease 3, autosomal dominant 10.1 LRRK2 SNCA
28 postencephalitic parkinson disease 10.1 LRRK2 SNCA
29 striatonigral degeneration 10.1 SLC6A3 SNCA
30 early-onset parkinson's disease 10.1 LRRK2 SNCA
31 autism 10.1
32 insulinoma 10.1
33 lymphoma 10.1
34 impulse control disorder 10.1
35 cerebellar degeneration 10.1
36 paraneoplastic cerebellar degeneration 10.1
37 myoclonus 10.1
38 encephalopathy 10.1
39 hypersomnia 10.1
40 neuronal intranuclear inclusion disease 10.1 RPS27A SNCA
41 cocaine abuse 10.1 SLC6A3 SNCA
42 parkinson disease 2, autosomal recessive juvenile 10.0 LRRK2 SNCA
43 obsessive-compulsive disorder 10.0
44 leukodystrophy, demyelinating, adult-onset, autosomal dominant 10.0
45 aging 10.0
46 alexithymia 10.0
47 leukodystrophy 10.0
48 tetanus 10.0
49 melanoma 10.0
50 post-traumatic stress disorder 10.0

Graphical network of the top 20 diseases related to Rem Sleep Behavior Disorder:



Diseases related to Rem Sleep Behavior Disorder

Symptoms & Phenotypes for Rem Sleep Behavior Disorder

MGI Mouse Phenotypes related to Rem Sleep Behavior Disorder:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 behavior/neurological MP:0005386 9.56 ACHE ATG4C HCRT LRRK2 MC1R SLC17A5
2 homeostasis/metabolism MP:0005376 9.17 ACHE ATG4C HCRT LRRK2 SLC17A5 SLC6A3

Drugs & Therapeutics for Rem Sleep Behavior Disorder

Drugs for Rem Sleep Behavior Disorder (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 65)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Suvorexant Approved, Investigational Phase 4 1030377-33-3
2
Mianserin Approved, Investigational Phase 4 24219-97-4 4184
3
Histamine Approved, Investigational Phase 4 51-45-6, 75614-87-8 774
4
Iodine Approved, Investigational Phase 4 7553-56-2 807
5
Melatonin Approved, Nutraceutical, Vet_approved Phase 4,Phase 2,Not Applicable 73-31-4 896
6 Antioxidants Phase 4,Phase 2,Not Applicable
7 Central Nervous System Depressants Phase 4,Phase 2,Not Applicable
8 Protective Agents Phase 4,Phase 3,Phase 2,Not Applicable
9 Neurotransmitter Agents Phase 4,Phase 3,Phase 2,Not Applicable
10 Orexin Receptor Antagonists Phase 4
11 Antidepressive Agents Phase 4
12 Histamine H1 Antagonists Phase 4
13 Histamine Antagonists Phase 4
14 Pharmaceutical Solutions Phase 4,Phase 2
15 Adrenergic alpha-Antagonists Phase 4
16 Adrenergic Agents Phase 4
17 Antidepressive Agents, Second-Generation Phase 4
18 Serotonin Agents Phase 4
19 Serotonin Antagonists Phase 4
20 Adrenergic Antagonists Phase 4
21
Histamine Phosphate Phase 4 51-74-1 65513
22 Psychotropic Drugs Phase 4
23 Calamus Phase 4
24 cadexomer iodine Phase 4
25
Serotonin Investigational, Nutraceutical Phase 4 50-67-9 5202
26
Acetylcholine Approved Phase 3 51-84-3 187
27
Rivastigmine Approved, Investigational Phase 3 123441-03-2 77991
28
Caffeine Approved Phase 3 58-08-2 2519
29 Cholinergic Agents Phase 3
30 Cholinesterase Inhibitors Phase 3
31 Neuroprotective Agents Phase 3
32 Purinergic P1 Receptor Antagonists Phase 3
33 Phosphodiesterase Inhibitors Phase 3
34 Central Nervous System Stimulants Phase 3
35
Sodium oxybate Approved Phase 2 502-85-2 5360545
36
Clonazepam Approved, Illicit Phase 2,Not Applicable 1622-61-3 2802
37
Iron Approved Phase 1, Phase 2 7439-89-6 23925
38
Penciclovir Approved Phase 1, Phase 2 39809-25-1 4725
39
Ethanol Approved Phase 2 64-17-5 702
40 Strawberry Approved Phase 2
41 Anesthetics, Intravenous Phase 2
42 Anesthetics, General Phase 2
43 Anesthetics Phase 2
44 Adjuvants, Anesthesia Phase 2
45 GABA Modulators Phase 2,Not Applicable
46 GABA Agents Phase 2,Not Applicable
47 Anticonvulsants Phase 2,Not Applicable
48 Anti-Inflammatory Agents Phase 2
49 Antipsychotic Agents Phase 2
50 Anti-Anxiety Agents Phase 2

Interventional clinical trials:

(show top 50) (show all 57)
# Name Status NCT ID Phase Drugs
1 Effect of Melatonin on Sleep Disturbances in Patients With Parkinson's Disease Unknown status NCT02768077 Phase 4 Melatonin(Circadin®);Placebo
2 Study to Determine Whether Ramelteon Helps People With REM Sleep Behavior Disorder Completed NCT01401413 Phase 4 ramelteon;placebo
3 Effect of Slow-release Melatonin (Circadin®) Therapy on Idiopathic RBD: a Pilot Study Recruiting NCT02836743 Phase 4 Circadin;Placebo
4 A Pilot Study of Suvorexant for Insomnia in Parkinson Disease Recruiting NCT02729714 Phase 4 Suvorexant;Placebo
5 Treatment of Sleep Disturbances in Trauma-affected Refugees Active, not recruiting NCT02761161 Phase 4 Mianserin
6 DaTSCAN Imaging in Aging and Neurodegenerative Disease Enrolling by invitation NCT01453127 Phase 4 I-123 Ioflupane solution injection prior to SPECT scan (DaTscan)
7 Effect of Melatonin on Sleep Disturbances in Patients With Parkinson's Disease Enrolling by invitation NCT03258294 Phase 4 Melatonin(Circadin®);Placebo Oral Tablet
8 Study of Rivastigmine to Treat Parkinsonian Apathy Without Dementia Completed NCT00767091 Phase 3 rivastigmine;placebo
9 Caffeine as a Therapy for Parkinson's Disease Completed NCT01738178 Phase 3 Caffeine;Placebo
10 Study of the Symptomatic Effects of Nocturnal Sodium Oxybate in Parkinson's Disease Unknown status NCT02111122 Phase 2 Sodium Oxybate
11 Effect of Clonazepam on REM Sleep Behavior Disorder in Patients With Parkinsonism Completed NCT02312908 Phase 2 Clonazepam;Placebo
12 Study Evaluating Nelotanserin for Treatment of REM Sleep Behavior Disorder in Subjects With Dementia (DLB or PDD) Completed NCT02708186 Phase 2 Nelotanserin;Placebo
13 Quantitative Mapping of Substantia Nigra Iron in Parkinson's Disease (Stages I-IV, REM Sleep Behavior Disorder) and Controls Recruiting NCT03675282 Phase 1, Phase 2 (11C)PE2I
14 A Study of Tolerability and Efficacy of Cannabidiol on Tremor in Parkinson's Disease Recruiting NCT02818777 Phase 2 cannabidiol;placebo
15 Identification of a Biomarker Predictive of Evolution of Parkinson Disease Recruiting NCT03230526 Phase 2 [18F]DPA-714 PET scan
16 A Study of Tolerability and Efficacy of Cannabidiol on Motor Symptoms in Parkinson's Disease Recruiting NCT03582137 Phase 2 Cannabidiol
17 Open-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior Disorder Active, not recruiting NCT02871427 Phase 2 Nelotanserin
18 Efficacy and Safety of Melatonin PR and Clonazepam in Patients With REM Sleep Behavior Disorder in Parkinson Disease Not yet recruiting NCT02789592 Phase 2 Melatonin PR;Clonazepam;Melatonin PR placebo;Clonazepam placebo
19 Adrenergic Blockers for Cardiac Changes in Early Parkinson's Disease Not yet recruiting NCT03775096 Phase 2 Carvedilol
20 Understanding the Natural History of REM Sleep Behavior Disorder Unknown status NCT01674998
21 Gait and REM Sleep Behavior Disorder Unknown status NCT02554331 Not Applicable
22 Exploring the Relationship Between Alpha-synucleinopathy Related Non-motor Symptom and Post-op. Delirium in Elderly Patients With Spine Surgery Unknown status NCT02550626
23 Exploration of the Reward System by Functional MRI in Parkinson's Disease Patients With and Without REM Sleep Behavior Disorder Completed NCT02824341 Not Applicable
24 Brain Imaging in the Idiopathic REM Sleep Behavior Disorder (ALICE) Completed NCT03072940
25 MRI Study of Brain Activity in Healthy Adults and Individuals With Parkinsonism and Rapid Eye Movement Disorder. Completed NCT01547481
26 SudoScan as a Biomarker of Parkinson's Disease Completed NCT02767037 Not Applicable
27 Cognitive Benefits of Treating Sleep Apnea in Parkinson's Disease Completed NCT00492115 Not Applicable
28 Establish a National Registry of REM Sleep Behavior Disorder Recruiting NCT03671798
29 Familial Aggregation and Biomarkers in REM Sleep Behaviour Disorder. Recruiting NCT03660982
30 Prodromal Markers of First-degree Relatives of Patients With Psychiatric Disorders Comorbid With RBD Recruiting NCT03595475
31 Exploration of the Reward System by Functional MRI in Narco-cataplexy Patients With and Without REM Sleep Behavior Disorder Recruiting NCT03425214 Not Applicable
32 Efficacy and Safety of Melatonin and Clonazepam for IRBD: Cross-over Study Recruiting NCT03255642 Not Applicable Melatonin 2mg;ClonazePAM 0.5 MG
33 Exploration of the Mechanism of Movement Improvement During RBD in Parkinson's Disease Using NIRS Recruiting NCT03060239 Not Applicable
34 RBD Longitudinal as Prognostic for PD Recruiting NCT00817726
35 Ultra High Field Magnetic Resonance Imaging as a Biomarker for Premotor Parkinson's Disease Recruiting NCT03288909
36 Striatal Dopamine Transmission in Individuals With Isolated Rapid Eye Movement Sleep With Atonia: a Search for Precursor Biomarker for Neurodegeneration Recruiting NCT03353207
37 Investigation of Clinical Feature and Brain Function in Narcoleptic Patients Recruiting NCT03376568
38 Natural History Study of Synucleinopathies Recruiting NCT01799915
39 Subcortical Oscillations in Human Sleep Dysregulation Recruiting NCT03377569
40 Sleep Structure in Refugees Diagnosed With PTSD Recruiting NCT03535636
41 Retinal Abnormalities as Biomarker of Disease Progression and Early Diagnosis of Parkinson Disease Recruiting NCT02640339
42 North American Prodromal Synucleinopathy Consortium Recruiting NCT03623672
43 Cognitive Behavioural Therapy for the Treatment of Late Life Depression Recruiting NCT03735576 Not Applicable
44 Cohort Study to Identify Predictor Factors of Onset and Progression of Parkinson's Disease Recruiting NCT02305147
45 Cognition and Obstructive Sleep Apnea in Parkinson's Disease, Effect of Positive Airway Pressure Therapy Recruiting NCT02209363 Not Applicable
46 Identification of Predictors for Early Cognitive Decline in Men Recruiting NCT03290040
47 Temporal Relationship Between Motor Fluctuations and Nonmotor Fluctuations Recruiting NCT02060695
48 Sporadic Degenerative Ataxia With Adult Onset: Natural History Study Recruiting NCT02701036
49 Detecting Parkinson's Disease Through Speech Analysis Active, not recruiting NCT03133611 Not Applicable
50 Prospective Neuroimaging Investigation of Idiopathic REM Sleep Behavior Disorder Active, not recruiting NCT02984137 Not Applicable

Search NIH Clinical Center for Rem Sleep Behavior Disorder

Cochrane evidence based reviews: rem sleep behavior disorder

Genetic Tests for Rem Sleep Behavior Disorder

Anatomical Context for Rem Sleep Behavior Disorder

MalaCards organs/tissues related to Rem Sleep Behavior Disorder:

41
Eye, Brain, Testes, Heart, Skin, Colon, Pons

Publications for Rem Sleep Behavior Disorder

Articles related to Rem Sleep Behavior Disorder:

(show top 50) (show all 642)
# Title Authors Year
1
Glucocerebrosidase gene variants are accumulated in idiopathic REM sleep behavior disorder. ( 29487000 )
2018
2
The clinical relevance of cognitive impairment in REM sleep behavior disorder. ( 29669910 )
2018
3
LRRK2 protective haplotype and full sequencing study in REM sleep behavior disorder. ( 29576439 )
2018
4
Predicting alpha-synuclein pathology by REM sleep behavior disorder diagnosis. ( 29779682 )
2018
5
REM sleep behavior disorder portends poor prognosis in Parkinson's disease: A systematic review. ( 29102236 )
2018
6
Presynaptic dopaminergic neuroimaging in REM sleep behavior disorder: A systematic review and meta-analysis. ( 29784534 )
2018
7
Longstanding disease-free survival in idiopathic REM sleep behavior disorder: Is neurodegeneration inevitable? ( 29724601 )
2018
8
REM Sleep Behavior Disorder and Alzheimer's Disease: Definitely No Relationship? ( 29578489 )
2018
9
Insights Into Polysomnography-Confirmed REM Sleep Behavior Disorder From New Prevalence and Gender Data in the General Population. ( 29390088 )
2018
10
Cortical and subcortical gray matter bases of cognitive deficits in REM sleep behavior disorder. ( 29669906 )
2018
11
Risk variants of the I+-synuclein locus and REM sleep behavior disorder in Parkinson's disease: a genetic association study. ( 29466944 )
2018
12
Ventromedial medulla inhibitory neuron inactivation induces REM sleep without atonia and REM sleep behavior disorder. ( 29402935 )
2018
13
Microstructural changes in patients with Parkinson disease and REM sleep behavior disorder: depressive symptoms versus non-depressed. ( 29442234 )
2018
14
The metabolic pattern of idiopathic REM sleep behavior disorder reflects early-stage Parkinson's disease. ( 29476004 )
2018
15
Observations on muscle activity in REM sleep behavior disorder assessed with a semi-automated scoring algorithm. ( 29353182 )
2018
16
Prospective memory in idiopathic REM sleep behavior disorder with or without mild cognitive impairment: a preliminary study. ( 29411691 )
2018
17
The prospective memory of patients with idiopathic REM sleep behavior disorder. ( 29880143 )
2018
18
Screening for idiopathic REM sleep behavior disorder: usefulness of actigraphy. ( 29554362 )
2018
19
How does dementia with Lewy bodies start? prodromal cognitive changes in REM sleep behavior disorder. ( 29665124 )
2018
20
REM Sleep Behavior Disorder. ( 29145189 )
2018
21
The REM sleep circuit and how its impairment leads to REM sleep behavior disorder. ( 29846796 )
2018
22
Case Report: Rapid Eye Movement Sleep Behavior Disorder as the First Manifestation of Multiple Sclerosis: A Case Report and Literature Review. ( 30150902 )
2018
23
Loss of Substantia Nigra Hyperintensity at 3.0-T MR Imaging in Idiopathic REM Sleep Behavior Disorder: Comparison with 123I-FP-CIT SPECT. ( 29232183 )
2018
24
The REM Sleep Behavior Disorder Screening Questionnaire is not Valid in De Novo Parkinson's Disease. ( 30009211 )
2018
25
REM Sleep Behavior Disorder (RBD) in Dementia with Lewy Bodies (DLB). ( 30018672 )
2018
26
Autonomic Sweat Responses in REM Sleep Behavior Disorder and Parkinsonism. ( 30040743 )
2018
27
Deterioration of executive dysfunction in elderly with REM sleep behavior disorder (RBD). ( 30048891 )
2018
28
The "when" and "where" of α-synucleinopathies: Insights from REM sleep behavior disorder. ( 30089622 )
2018
29
Pharmacological treatment for REM sleep behavior disorder in Parkinson disease and related conditions: A scoping review. ( 30118919 )
2018
30
Heart rate variability in Parkinson disease and idiopathic REM sleep behavior disorder. ( 30128681 )
2018
31
Objective intestinal function in patients with idiopathic REM sleep behavior disorder. ( 30143390 )
2018
32
Circadian rhythms of melatonin and peripheral clock gene expression in idiopathic REM sleep behavior disorder. ( 30195196 )
2018
33
Alpha-synuclein aggregates in the parotid gland of idiopathic REM sleep behavior disorder. ( 30195197 )
2018
34
Smartphone motor testing to distinguish idiopathic REM sleep behavior disorder, controls, and PD. ( 30232246 )
2018
35
REM Sleep without Atonia with REM Sleep-Related Motor Events: Broadening the Spectrum of REM Sleep Behavior Disorder. ( 30239958 )
2018
36
Novel biomarker signatures for idiopathic REM sleep behavior disorder: A proteomic and system biology approach. ( 30258025 )
2018
37
Effect of serum uric acid on cognition in patients with idiopathic REM sleep behavior disorder. ( 30284075 )
2018
38
Association between clinically probable REM sleep behavior disorder and tetanus in dogs. ( 30315605 )
2018
39
Clinical and genetical study of a familial form of REM sleep behavior disorder. ( 30419424 )
2018
40
Vestibular Evoked Myogenic Potentials Are Abnormal in Idiopathic REM Sleep Behavior Disorder. ( 30420831 )
2018
41
Abnormal Activation of Motor Cortical Network during Phasic REM Sleep in Idiopathic REM Sleep Behavior Disorder. ( 30445515 )
2018
42
Validation of a new data-driven automated algorithm for muscular activity detection in REM sleep behavior disorder. ( 30468824 )
2018
43
The risk of neurodegeneration in REM sleep behavior disorder: A systematic review and meta-analysis of longitudinal studies. ( 30503716 )
2018
44
Response to "prospective memory impairment in idiopathic REM sleep behavior disorder". ( 30522874 )
2018
45
Novel biomarker signatures for idiopathic REM sleep behavior disorder: A proteomic and system biology approach. ( 30530562 )
2018
46
Protective effects of REM sleep without atonia against obstructive sleep apnea in patients with idiopathic REM sleep behavior disorder. ( 30553182 )
2018
47
Difference in severity of sleep apnea in patients with rapid eye movement sleep behavior disorder with or without parkinsonism. ( 30093262 )
2018
48
Effect of Rapid Eye Movement Sleep Behavior Disorder on Obstructive Sleep Apnea Severity and Cognition of Parkinson's Disease Patients. ( 29664048 )
2018
49
LC-MS/MS glycomics of idiopathic rapid eye movement sleep behavior disorder. ( 30168606 )
2018
50
Link Between Parkinson Disease and Rapid Eye Movement Sleep Behavior Disorder With Dream Enactment: Possible Implications for Early Rehabilitation. ( 28890381 )
2018

Variations for Rem Sleep Behavior Disorder

Expression for Rem Sleep Behavior Disorder

Search GEO for disease gene expression data for Rem Sleep Behavior Disorder.

Pathways for Rem Sleep Behavior Disorder

GO Terms for Rem Sleep Behavior Disorder

Cellular components related to Rem Sleep Behavior Disorder according to GeneCards Suite gene sharing:

(show all 12)
# Name GO ID Score Top Affiliating Genes
1 axon GO:0030424 9.65 LRRK2 SLC6A3 SNCA
2 lysosome GO:0005764 9.63 LRRK2 SLC17A5 SNCA
3 mitochondrial outer membrane GO:0005741 9.58 LRRK2 RPS27A SNCA
4 cell junction GO:0030054 9.55 ACHE HCRT LRRK2 SLC17A5 SNCA
5 synaptic vesicle GO:0008021 9.5 HCRT LRRK2 SNCA
6 rough endoplasmic reticulum GO:0005791 9.49 HCRT SNCA
7 terminal bouton GO:0043195 9.43 LRRK2 SNCA
8 postsynapse GO:0098794 9.43 HCRT LRRK2 SNCA
9 inclusion body GO:0016234 9.37 LRRK2 SNCA
10 synaptic vesicle membrane GO:0030672 9.13 LRRK2 SLC17A5 SNCA
11 synapse GO:0045202 9.02 ACHE HCRT LRRK2 SLC17A5 SNCA
12 plasma membrane GO:0005886 10.05 ACHE LRRK2 MC1R RPS27A SLC17A5 SLC6A3

Biological processes related to Rem Sleep Behavior Disorder according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 negative regulation of neuron death GO:1901215 9.46 LRRK2 SNCA
2 receptor internalization GO:0031623 9.43 ACHE SNCA
3 response to cocaine GO:0042220 9.4 SLC6A3 SNCA
4 regulation of neurotransmitter secretion GO:0046928 9.37 HCRT SNCA
5 regulation of neuron death GO:1901214 9.32 LRRK2 SNCA
6 neurotransmitter biosynthetic process GO:0042136 9.26 ACHE SLC6A3
7 dopamine biosynthetic process GO:0042416 9.16 SLC6A3 SNCA
8 regulation of locomotion GO:0040012 8.96 LRRK2 SNCA
9 excitatory postsynaptic potential GO:0060079 8.8 HCRT LRRK2 SNCA

Sources for Rem Sleep Behavior Disorder

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....